<DOC>
	<DOCNO>NCT00148031</DOCNO>
	<brief_summary>The overall goal research project improve outcome medical care injection drug user ( IDUs ) Hepatitis C viral ( HCV ) infection . Hypothesis : An intervention design improve rate HCV treatment completion sustain virologic response ( SVR ) IDUs increase access integrate HCV medical care substance abuse treatment program .</brief_summary>
	<brief_title>Improving Hepatitis C Treatment Injection Drug Users</brief_title>
	<detailed_description>The overall goal propose health service research project improve outcome medical care injection drug user ( IDUs ) Hepatitis C viral ( HCV ) infection . This do testing intervention design improve rate HCV treatment completion sustain virologic response ( SVR ) IDUs . This intervention increase access integrate HCV medical care substance abuse treatment program . HCV infection endemic among IDUs , associate significant medical morbidity . While antiviral treatment improve rapidly , provide HCV medical care IDUs remain problematic number reason . IDUs often adequate access HCV diagnosis treatment service , may co-morbid psychiatric diagnosis affect ability withstand demand HCV treatment . Therefore , study also examine psychiatric disorder psychiatric symptom IDUs infect Hepatitis C virus . The propose project five-year program consist control clinical trial , study 220 patient HCV infection enrol methadone maintenance treatment ( MMT ) . The HCV Medical Care Study randomize trial test efficacy On-site HCV Medical Care provide MMT program versus Off-site care Gastroenterology ( GI ) Clinic . HCV antibody positive MMT patient ( N=220 ) randomly assign receive HCV medical service either integrated delivery model locate on-site MMT clinic , usual off-site referral GI Clinic . The main outcome rate attain SVR completion HCV treatment , well measure HCV-related health outcome quality life . Participants evaluate Axis I psychiatric diagnosis complete psychiatric measure monthly interval throughout study . Psychiatric diagnosis make use Structured Psychiatric Interview DSM-IV ( SCID ) psychiatric symptom severity assess depression , mania , anxiety , psychosis . Drug use measure , quality life measure also obtain . These data expect yield new knowledge efficacy provide on-site HVC medical care substance abuse treatment program . They provide comparison psychiatric diagnosis psychiatric symptom presentation HCV positive IDUs choose receive HCV treatment choose follow HCV treatment describe change psychiatric symptom , , HCV medical care . Finally , study also provide information influence psychiatric symptom drug alcohol use HCV medical outcome treatment completion SVR .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<criteria>1 . 1865 year age . 2 . Enrolled outpatient methadone maintenance treatment great 3 month . 3 . Hepatitis C RNA positive . 4 . Willingness accept HCV treatment . 5 . Subject nonVA ( Veteran 's Administration ) medical insurance willing bear expense associate Hepatitis C medical treatment . 1 . In need inpatient drug alcohol detoxification . 2 . Currently receive standard Hepatitis C treatment 3 . Unable give adequate inform consent . 4 . Pregnant , nursing , plan become pregnant HCV treatment within 6 month follow completion treatment . 5 . Male subject female sexual partner pregnant planning become pregnant time HCV treatment within 6 month follow completion treatment . 6 . Female subject male subject female sexual partner child bearing year use two medically approve form contraception . 7 . Subject make commitment attend residential care psychiatric drug/alcohol rehabilitation , would lead unavailability attend regularly schedule medical care research visit . 8 . Subject attend require screening appointment . 9 . Subject legal proceeding whose outcome may lead incarceration within 3 month intake .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>behavior modification</keyword>
	<keyword>health care service utilization</keyword>
	<keyword>hepatitis C ,</keyword>
	<keyword>injection drug use</keyword>
	<keyword>therapy compliance</keyword>
	<keyword>alcoholism</keyword>
	<keyword>alcohol abuse</keyword>
	<keyword>prevention</keyword>
	<keyword>drug abuse</keyword>
	<keyword>liver disorder</keyword>
	<keyword>HCV</keyword>
	<keyword>methadone</keyword>
</DOC>